Glucagon receptor activation increases hepatic fat oxidation, making MASLD a high-conviction indication for the triple agonist mechanism
Steady State Timeline by Dose Level These timelines follow the lexicon standard titration (2mg to 4mg to 8mg to 12mg, every 4 weeks) combined with the 4-to-5-week steady-state rule
This potential use would be informal initially, as there is very little or no formal clinical guidance on the use of pharmacotherapy to maintain weight loss, but as clinical trials have shown that people who discontinue AOMs typically regain weight, it is highly likely that real world use of these agents will include use to maintain weight loss and therefore that lower cost semaglutide may be preferred
Notwithstanding progress in promoter designs and delivery mechanisms, sustained expression and selective absorption continue to pose challenges
Thus, protein intake, alongside physical activity, remains a priority to minimise muscle loss for GLP-1 users
Vers le haut de la page
